ClinicalTrials.gg
RecruitingNCT06553313Updated Aug 14, 2024

Analysis of Protein Expression in Serum of KOA Subjects

An interventional study of Micro-Western Array in Knee Osteoarthritis, sponsored by China Medical University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-14.

Sponsored by China Medical University Hospital · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Osteoarthritis, Knee by China Medical University Hospital — 1 open to participants now, 1 under way, none of them phase 3. Osteoarthritis, Knee · China Medical University Hospital.

Planned enrollment
4th of 10
50 · median 44
Started
2024
the only one that year
No phase
9 of 10
1 open now
Registered
10th of 10
by date

Among the 10 studies in Osteoarthritis, Knee by China Medical University Hospital, this one is the 4th largest by planned enrollment, is the only one that started in 2024, is one of 9 with no phase, and was the 10th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

1 of the 10 studies in Osteoarthritis, Knee by China Medical University Hospital is open now, in 1 country.

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 50 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Osteoarthritis, Knee by China Medical University Hospital, or all of them as a file.
02

Study summary

In the previous study "Using omics technology to explore the mechanism of acupuncture treatment of different acupoints of knee osteoarthritis: a randomized controlled trial (CMUH109-REC3-113)", we found that acupuncture for knee osteoarthritis(KOA) significantly reduces inflammation, apoptosis, and metabolism-related serum protein profiles. However, due to the lack of serum protein data from the control group, it is impossible to establish standard values for comparison. To analyze the protein expression in the serum of KOA control group subjects, we also measured the spectral energy values of the radial artery pulse wave obtained from the pulse sphygmograph and the meridian energy values obtained from Ryodoraku. The results obtained can be compared with previous studies, thus this experiment was designed.

03

Conditions studied

  • Knee Osteoarthritis
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults over 50 years old without knee pain

Exclusion criteria

Exclusion Criteria:

  1. Clinical diagnosis of knee osteoarthritis
  2. Taking anti-inflammatory and analgesic drugs in the past month
  3. Taking blood-lipid-lowering drugs or health foods in the past month
  4. Received any acupuncture treatment in the past 3 weeks
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Other
    the control group of knee arthritis

    Monitoring the stability of protein expression, pulse wave and meridian energy in the serum of the KOA control group (participants without knee pain).

    Device: Micro-Western Array

Interventions

  • DeviceMicro-Western Array

    The subjects first took the energy measurement of the pulse sphygmograph and Ryodoraku, rested for 20 minutes, and then repeated the measurements again. In order to comply with the acupuncture treatment course was 5 weeks in the previous study, we have two blood draw point. Each subject's blood was drawn for the first time, and then for the second time in 5 weeks later. Each subject drew 10ml of blood each time. The blood samples are analyzed by Micro-Western Array (MWA) and Enzyme-linked immunosorbent assay (ELISA) to obtain the serum protein content value of healthy individuals.

    Also known as: Enzyme-linked immunosorbent assay, pulse sphygmograph, Ryodoraku

06

What researchers measure

Primary outcomes

  1. Micro-Western Array and Enzyme-linked immunosorbent assay

    Obtaining the serum protein content value

    Time frame: the first and the fifth weeks

Secondary outcomes

  1. pulse sphygmograph and Ryodoraku

    the energy measurement of pulse and meridians

    Time frame: the first and the fifth weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Jul 2025, 11 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 11 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2024
First posted
Aug 14, 2024
StartActual
Aug 4, 2024
Primary completionEst.
Jul 23, 2025
CompletionEst.
Jul 23, 2025
Last update
Aug 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06553313
Responsible party
Sponsor
First posted
Aug 14, 2024
Start date
Aug 4, 2024
Primary completion
Jul 23, 2025 (estimated)
Completion
Jul 23, 2025 (estimated)
Last update
Aug 14, 2024

Study contacts

Wan-Zhen Yu
Contact
a030037@gmail.com
8864-22053366 ext. 3500
Yu-Chen Lee
Contact
005167@tool.caaumed.org.tw
8864-22053366 ext. 3500
Wan-Zhen Yu
principal investigator · China Medical University, China

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion